BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 6622938)

  • 1. Treatment of idiopathic polyradiculoneuropathies by plasma exchange.
    Marconi G; Avanzi G; Lombardo R; Ronchi O; Taiuti R; Pizzi A
    Riv Patol Nerv Ment; 1983; 103(3):114-32. PubMed ID: 6622938
    [No Abstract]   [Full Text] [Related]  

  • 2. [Biological abnormalities in the initial stage of Guillain-Barré syndrome].
    Resimont S; Vanderheyden JE; Jacquy J; Meunier JC; Kennes B
    Rev Med Brux; 1987 Jan; 8(1):3-9. PubMed ID: 3563182
    [No Abstract]   [Full Text] [Related]  

  • 3. Plasmapheresis in the treatment of four cases of Guillain-Barré syndrome (acute form).
    Zerbi D; Celano I; Forlani G; Garelli S; Mosconi L; Valbonesi M
    Ital J Neurol Sci; 1981 Dec; 2(4):331-6. PubMed ID: 7333823
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immune complex levels and plasmapheresis in Guillain-Barré syndrome.
    Tharakan JK; Mathai J; Mathai A; Sulochana PV
    Acta Neurol (Napoli); 1993 Apr; 15(2):138-41. PubMed ID: 8328324
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cerebrospinal fluid pheresis in Guillain Barré syndrome.
    Wollinsky KH; Hülser PJ; Westarp ME; Mehrkens HH; Kornhuber HH
    Med Hypotheses; 1992 Jun; 38(2):155-65. PubMed ID: 1528158
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Removal ability of immunoglobulins in plasma exchange and double-filtration plasmapheresis].
    Tagawa Y; Yuki N
    Rinsho Shinkeigaku; 1997 May; 37(5):410-2. PubMed ID: 9294330
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of plasmapheresis in active systemic lupus erythematosus.
    Kater L; Derksen RH; Houwert DA; Hené RJ; Struyvenberg A; Gmelig Meyling FH; Verroust P
    Neth J Med; 1981; 24(6):209-16. PubMed ID: 7322246
    [No Abstract]   [Full Text] [Related]  

  • 8. Treatment of chronic relapsing inflammatory polyradiculoneuropathy by plasma exchange.
    Server AC; Lefkowith J; Braine H; McKhann GM
    Ann Neurol; 1979 Sep; 6(3):258-61. PubMed ID: 534424
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Exchange plasmapheresis in combined treatment of severe uveitis].
    Chentsova OB; Grechanyĭ MP; Kil'diushevskiĭ AV
    Vestn Oftalmol; 1989; 105(1):40-3. PubMed ID: 2718309
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Plasmapheresis in neurological diseases].
    Oikarinen R
    Duodecim; 1990; 106(7):553-4. PubMed ID: 1670211
    [No Abstract]   [Full Text] [Related]  

  • 11. Papilledema in idiopathic inflammatory polyradiculoneuropathy.
    Sozzi G; Marotta P
    Ital J Neurol Sci; 1986 Feb; 7(1):97-100. PubMed ID: 3957638
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Cerebrospinal fluid findings in Guillain-Barré-Strohl syndrome].
    Schmidt RM
    Z Arztl Fortbild (Jena); 1981 Dec; 75(23):1095-8. PubMed ID: 6176077
    [No Abstract]   [Full Text] [Related]  

  • 13. [Plasmapheresis in 2 children with Guillain-Barré syndrome].
    Rotteveel JJ; Mullaart RA; Weemaes CM; van Empelen R
    Tijdschr Kindergeneeskd; 1983 Apr; 51(2):57-62. PubMed ID: 6879585
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Recurrence of Guillain-Barré syndrome treated by plasma exchange. Parallel courses of clinical symptoms and circulating immune complexes].
    Squara P; Quaranta JF; Viguier E; Cassuto JP; Maiolini R; Canivet B; Mattei M; Duplay H; Dujardin P
    Nouv Presse Med; 1981 Dec; 10(47):3854-5. PubMed ID: 7329799
    [No Abstract]   [Full Text] [Related]  

  • 15. [Changes in cerebrospinal fluid immunoglobulins during multiple sclerosis].
    Musiani P; Giovannini G; Pozzuoli R
    Riv Patol Nerv Ment; 1969 Apr; 90(2):99-112. PubMed ID: 5000385
    [No Abstract]   [Full Text] [Related]  

  • 16. [Treatment of Guillain-barre syndrome: immunoglobulins or plasmapheresis?].
    Martínez Yélamos A; Huerta Villanueva M; Olivé Plana M; Montero Homs J; Serra Catafau J; Martínez-Matos JA
    Neurologia; 1998 Apr; 13(4):166-9. PubMed ID: 9608755
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Protein fractions in the cerebrospinal fluid and blood in cases of brain concussion].
    Mrówka R; Bielska J
    Pol Tyg Lek; 1978 May; 33(19):765-7. PubMed ID: 662780
    [No Abstract]   [Full Text] [Related]  

  • 18. [Comparative study of the efficacy of plasma exchange, immunoadsorption plasmapheresis and corticosteroid administration in the treatment of Guillain-Barré syndrome].
    Yamazaki M; Koh CS; Hanyu N; Sakai T; Inoue A; Yanagisawa N
    Arerugi; 1995 Apr; 44(4):498-502. PubMed ID: 7598643
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Guillain-Barre syndrome. Current treatment principles in the light of clinical aspects].
    Gerdts R; Jensen D; Fauchald P; Skjeldal O
    Tidsskr Nor Laegeforen; 1999 Feb; 119(4):506-9. PubMed ID: 10081373
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Abnormalities of cerebrospinal fluid amino acids in patients with the Guillain-Barré syndrome.
    Corston RN; McGale EH; Stonier C; Aber GM; Hutchinson EC
    J Neurol Neurosurg Psychiatry; 1981 Jan; 44(1):86-9. PubMed ID: 7205311
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.